[New techniques in maxillofacial surgery: local injection treatment with botulinum toxin A]. / Neuerungen in der MKG-Chirurgie: Lokale Injektionsbehandlung mit Botulinumtoxin A.
Mund Kiefer Gesichtschir
; 2 Suppl 1: S121-4, 1998 May.
Article
en De
| MEDLINE
| ID: mdl-9658837
ABSTRACT
Intramuscular injections of botulinum neurotoxin type A cause reversible chemodenervation and subsequent paralysis by blocking the presynaptic release of acetylcholine. Botulinum toxin type A has emerged as the most effective form of symptomatic treatment for abnormabilities in muscle movement (blepharospasm, hemifacial spasm, torticollis) and has been approved for use in these conditions. First results in the treatment of patients suffering from oromandibular dystonia, myogenic craniomandibular dysfunction and recurrent dislocation of the temporomandibular joint are presented. In most cases, therapeutic effects occurred within 1-6 days post-injection. Muscular hyperfunction was reliably reduced and involuntary activity patterns gradually ceased. No severe side effects of the local injections were noted.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Toxinas Botulínicas Tipo A
/
Distonía
/
Músculos Faciales
/
Desnervación Muscular
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
De
Revista:
Mund Kiefer Gesichtschir
Asunto de la revista:
ODONTOLOGIA
Año:
1998
Tipo del documento:
Article